You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Novel Low Cost, High Efficiency, Algal Biomass Harvest and Dewatering Technology for Biodiesel Production

    SBC: ACENT LABORATORIES LLC            Topic: 26d

    Biodiesel produced from microalgae has been identified as a potential source of affordable renewable fuel. This project addresses one aspect of the algal biodiesel production chain: development of low-cost, high-efficiency algal biomass harvest and dewatering technology. The approach involves the development and verification of system models of the entire algae-to-biodiesel production chain. These ...

    SBIR Phase I 2008 Department of Energy
  2. High Power Fundamental Power Coupler for Next Generation Light Sources

    SBC: Advanced Energy Systems, Inc            Topic: 03c

    Future third-generation light sources, such as the NSLS-II synchrotron light source proposed for Brookhaven National Laboratory, push the operating current and subsequent beam power to levels beyond the capabilities of single CESR-B cavities. The proposed light source will require 500mA and 1000kW of radiated beam power that must be provided through the power couplers/windows. This project will de ...

    SBIR Phase I 2008 Department of Energy
  3. Development of Alternative Reduced-Cost Helium Vessels for ILC Cavities

    SBC: Advanced Energy Systems, Inc            Topic: 48a

    The International Linear Collider represents the next great undertaking for the worldwide high energy physics community. In addition to the technical challenges, the political realities demand that ILC R&D focus on reducing the cost of the components of this massive facility. The helium vessels that enclose each of the 16,000 superconducting cavities have been identified as a cost driver for the c ...

    SBIR Phase I 2008 Department of Energy
  4. Improved Superconducting Accelerator System for Next Generation Light Sources

    SBC: Advanced Energy Systems, Inc            Topic: 03c

    Modern synchrotron light sources have come to rely upon superconducting radio frequency (SRF) acceleration to achieve high luminosity. To date, the workhorse in this area has been the SRF system for the CESR-B machine, which has been employed on many light sources in the last several years. However, as the quest for higher performance continues, this system is being stretched beyond its design lim ...

    SBIR Phase I 2008 Department of Energy
  5. Nanoliter Lab-on-a-Chip for Rapid Parallel Immunoassays

    SBC: ADVANCED LIQUID LOGIC            Topic: N/A

    DESCRIPTION (provided by applicant): The great need for more efficient and effective oncologic drug development has driven the discovery and integration of biomarkers into all phases of clinical research. Further still, biomarkers are entering the clinical arena as early means of determining which patients are likely benefiting from a particular drug. One field of targeted therapy that has relied ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Multiplexing Cancer Sample Preparation: Indirect Immunomagnetic Enrichment

    SBC: ADVANCED LIQUID LOGIC            Topic: N/A

    DESCRIPTION (provided by applicant): Biomarkers of clinical activity are critical for targeted anti-cancer therapy development and are becoming important for the care of individual patients. In a prototypical tyrosine kinase pathway, governed by the epider mal growth factor receptor (EGFR), functional activity of the pathway is assessed by the phosphorylation status of EGFR and downstream signalin ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Improved Silicon Drift Detector Coincidence Rejection for Digital Pulse Processors

    SBC: 4pi Analysis, Inc.            Topic: N/A

    The recent emergence of the Silicon Drift detector (SDD), for use in Energy Dispersive x-ray Spectroscopy (EDS), has made possible x-ray event streams with input count rates in the range of 1-10 Mcps. Modern digital pulse processors are therefore required to run at fast time constants to achieve reasonable throughput; however, this causes significant coincidence artifacts to appear in the spectrum ...

    SBIR Phase I 2008 Department of CommerceNational Institute of Standards and Technology
  8. Localized Growth Factor Therapy for Surgical Hernia Repair

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Over 700,000 surgical hernia repairs are performed each year in the United States and despite recent advances, a significant rate of recurrence persists. The incorporation of biocompatable mesh to strengthen the abdomi nal fascia has largely replaced high-tension suturing techniques in hernia repair. Currently, the preferred biomaterials include durable synthe ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  9. Antibiotic-binding Peptides for Biofilm Prevention on Ventriculoperitoneal Shunts

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Ventriculoperitoneal (VP) shunts are used to treat pediatric and neonatal hydrocephalus in severe cases, representing approximately 1/3rd of affected infants. Due to the high susceptibility for infection and mechanica l breakdown, the failure rate of VP shunts is around 30-40%. A need therefore exists to improve infection prevention for this procedure, likely ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Tissue-targeted Antibiotics for the Prevention of Surgical Site Infection

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The Centers for Disease Control estimates that as many as 2 million people contract infections in hospitals each year, with as many as 100,000 deaths. Approximately 1/4 of hospital related infections (~500,000) are surg ical site infections. For each single patient, surgical site infections have been reported to require a median 6.5 additional days of hospital ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government